Potential therapeutic strategies to overcome this mechanism include inducing MHC-I expression in cancer via nuclear factor kappa beta (NFκB) stabilization, regulation of NFκB expression, or inducing MHC-I expression via restored IFN signaling. The gene discussed is NFKB1; the disease is cancer.